Optiject (Ioversol)

Ioversol, the active ingredient in Optiject, is a iodinated contrast media presented as a sterile injectable solution for intravascular use. It enhances X‑ray attenuation to improve visualization of anatomical structures during diagnostic imaging procedures. GNH USA supplies Optiject as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Optiject (ioversol) is employed in radiographic procedures that require enhanced X‑ray visibility. - Computed Tomography (CT) imaging: provides high‑contrast enhancement of vascular and soft‑tissue structures for accurate diagnosis. - Angiography: delineates blood‑vessel anatomy during catheter‑based interventions, aiding therapeutic decisions. - Intravenous urography: improves visualization of the urinary tract, facilitating detection of obstruction or lesions.

Adverse reactions to Optiject may vary in frequency and severity.

Common Side Effects: - Warmth or flushing sensation at the injection site - Metallic taste in the mouth - Nausea or mild vomiting - Headache - Transient urticaria or itching - Mild hypotension

Serious or Rare Side Effects: - Anaphylactic or severe allergic reaction - Acute kidney injury, especially in patients with pre‑existing renal impairment - Seizures or convulsions - Cardiac arrhythmias or severe hypotension - Pulmonary edema or respiratory distress - Persistent severe hypertension

Prior to administering Optiject, clinicians should consider several safety measures. - Assess renal function: evaluate baseline creatinine or eGFR to identify patients at risk of nephrotoxicity. - Screen for iodine allergy: avoid use in individuals with known hypersensitivity to iodinated contrast agents. - Ensure adequate hydration: maintain fluid balance to reduce renal adverse effects. - Pregnancy considerations: use only when essential, weighing potential fetal exposure against diagnostic benefit. - Thyroid monitoring: be cautious in patients with hyperthyroidism or thyroid disorders. - Store at ambient temperature: keep in original container, protect from light and moisture.

Ioversol may interact with other medicines, influencing safety or efficacy.

Major Interactions (Avoid): - Concurrent nephrotoxic drugs (e.g., aminoglycosides, high‑dose NSAIDs): increase risk of renal injury. - High‑dose iodine‑containing medications (e.g., amiodarone, potassium iodide): cumulative iodine load may exacerbate thyroid dysfunction. - Radiopharmaceuticals: may interfere with nuclear imaging results.

Moderate Interactions (Monitor Closely): - Beta‑blockers: monitor blood pressure as contrast can cause transient hypotension. - Diuretics: adjust fluid management to maintain hydration status. - Metformin: hold for 48 hours after contrast in patients with impaired renal function to prevent lactic acidosis.